Chargement en cours...
Growth and bone health in paediatric patients with Crohn's disease receiving subcutaneous tumor necrosis factor antibody
AIM: To study whether adalimumab (ADA) was associated with improvement in growth, bone mineral density (BMD) and bone metabolism. METHODS: In children with Crohn’s disease (CD) there is a high prevalence of growth failure and reduced BMD. Treatment with infliximab is associated with an improvement i...
Enregistré dans:
| Publié dans: | World J Gastroenterol |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Baishideng Publishing Group Inc
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4458771/ https://ncbi.nlm.nih.gov/pubmed/26074699 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i21.6613 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|